Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 98

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 9B
Chunk 98
---
During
the quarter ended December 31, 2024, none of our directors or executive officers adopted, modified, or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Rule 408 of Regulation
S-K.

ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

Not
applicable.

PART
III

ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The
information required by this item is incorporated by reference from the information contained in our Definitive Proxy Statement to be
filed with the Securities and Exchange Commission in connection with the Annual Meeting of Stockholders to be held in 2025 (the “2025
Proxy Statement”), under the heading “Election of Directors.”

ITEM
11. EXECUTIVE COMPENSATION

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the heading
“Executive Compensation.”

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the headings
“Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the headings
“Family Relationships and other Arrangements.”

ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The
information required by this item is incorporated by reference from the information contained in the 2025 Proxy Statement under the heading
“Proposal 2: Ratification of the Appointment of Our Independent Registered Public Accounting Firm for Fiscal Year Ending December
31, 2025.”

-36-

PART
IV

ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)
The following documents are filed as part of this report:

    (1)
    Financial
    Statements:

    Page
  
    Index to Consolidated Financial Statements:
    F-1

    Consolidated
    Financial Statements:

    Report of the Independent Registered Public Accounting Firm
    F-2